| [1] |
Rosenbaum P, Paneth N, Leviton A, et al. A report: The definition and classification of cerebral palsy April 2006[J]. Dev Med Child Neurol, 2007, 109:8-14.
|
| [2] |
Graham HK.Botulinum toxin-A in cerebral palsy:Functional outcomes[J]. J Pediatr, 2000, 137(3):300-303.
|
| [3] |
McConnell K, Johnston L, Kerr C. Upper limb function and deformity in cerebral palsy: A review of classification systems[J]. Dev Med Child Neurol, 2011, 53(9):799-805.
|
| [4] |
Odderson IB.Botulinum toxin injection guide[M]. Beijing:Peking University Medical Press, 2009, 61-62.
|
| [5] |
Yang H, Shi W, Wang S, et al. Reliability and validity of Peabody Developmental Motor Scale in assessment of infants and toddlers[J]. Chin J Child Health Care, 2010, 18(2):121-123.
|
| [6] |
Luo R, Mao M.Application of botulinum toxin on cerebral hemiplegal in children[J]. J Appl Clin Pediatr, 2005, 20(6):594-596.
|
| [7] |
Wang Q, Luo R, Zhang L, et al.Botulinum toxin A in hemiparetic cerebral palsy:40 cases report[J/CD].Chin J Obstet Gynecol Pediatr: Electron Ed, 2007, 3(6):333-334.
|
| [8] |
Speth LA, Leffers P, Janssen-Potten YJ, et al. Botulinum toxin A and upper limb functional skills in hemiparetic cerebral palsy: A randomized trial in children receiving intensive therapy[J]. Dev Med Child Neurol, 2005, 47(7):468-473.
|
| [9] |
Wallen M, O'Flaherty SJ, Waugh MC. Functional outcomes of intramuscular botulinum toxin type A and occupational therapy in the upper limbs of children with cerebral palsy: A randomized controlled trial[J]. Arch Phys Med Rehabil, 2007, 88(1):1-10.
|
| [10] |
Desloovere K, Molenaers G, De Cat J, et al. Motor function following multilevel botulinum toxin type A treatment in children with cerebral palsy[J]. Dev Med Child Neurol, 2007, 49(1):56-61.
|
| [11] |
O'Flaherty SJ, Janakan V, Morrow AM, et al. Adverse events and health status following botulinum toxin type A injections in children with cerebral palsy[J]. Dev Med Child Neurol, 2011, 53(2):125-130.
|